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Effect of Coexposure to Asbestos and Kerosene
Soot on Pulmonary Drug-Metabolizing Enzyme
System
J. M. Arif, S. G. Khan, N. Mahmood, M. Aslam, and Q. Rahman
Fiber Toxicology Division, Industrial Toxicology Research Center, M.G. Marg, Lucknow, India
This article reports the effect of coexposure to Indian chrysotile asbestos (5 mg/rat) and kerosene soot (5 mg/rat) on the pulmonary phase and
phase 11 drug-metabolizing enzymes 1, 4, 8, 16, 30, 90, and 150 days after a single intratracheal inoculation. Exposure to soot resulted in a signifi-
cant induction of the pulmonary microsomal cytochrome P450 and the activity of dependent monooxygenase, benzo[alpyrene (B[a]P) hydroxylase,
and epoxide hydrase at all time intervals. On the other hand, the cytosolic glutathione S-transferase (GST) activity was induced at days 1, 4, 8, 16,
and 30 after exposure, followed by inhibition in the enzyme activity. In contrast, chrysotile exposure depleted cytochrome P450, B[aiP hydroxylase,
epoxide hydrase, and GST at initial stages, while all these parameters except GST were induced at later stages. However, coexposure to chrysotile
and soot led to a significant inhibition in the cytochrome P450 levels, activities of B[a]P hydroxylase, epoxide hydrase, and GST at initial stages of
exposure. At advanced stages, however, an additional increase in cytochrome P450, B[a]P hydroxylase, and epoxide hydrase but a decrease in GST
was observed. These results clearly show that the intratracheal coexposure to high levels of asbestos and kerosene soot alters the metabolic activ-
ity of the lung, which in turn may retain toxins in the system for a longer period, resulting in adverse pathological disorders. - Environ Health
Perspect 102(Suppl 5):181-183 (1994)
Key words: asbestos, kerosene soot, drug-metabolizing enzymes, rat lung
Introduction
Occupational exposure to asbestos pro-
duces both malignant (bronchogenic carci-
noma, mesothelioma) and nonmalignant
(lung and pleural fibrosis) diseases in the
respiratory tract (1). In India, the majority
of asbestos factory workers use kerosene as
a domestic fuel because of its low cost.
This creates the possibility of their expo-
sure to asbestos at the workplace and to
combustion products of kerosene (soot) at
home, which may create serious health
problems. Earlier reports have suggested
that the continuous derangement in the
pulmonary drug-metabolizing enzyme sys-
tems by asbestos affects the metabolism
and clearance of a variety ofenvironmental
pollutants reaching the lung (2-4).
Because kerosene soot has both aliphatic
and aromatic hydrocarbons (3,5), these
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hydrocarbons, which would be metabolized
by cytochrome P450 dependent monooxy-
genase, may metabolize in the presence of
asbestos, so that their persistence, and
hence, toxic responses in the system may be
affected. In this article, we report the effect
ofcoexposure to Indian chrysotile asbestos
and kerosene soot on the pulmonary phase
I and phase II drug-metabolizing enzymes
after 1, 4, 8, 16, 30, 90, and 150 days of
exposure.
Materials and Methods
All the chemicals and reagents used were
acquired either from Sigma Chemical
Company, (St. Louis, MO) or Spectro-
chem Pvt. Ltd. (India), and were ofanalyti-
cal grade. Kerosene soot was prepared by
burning the commercial grade kerosene (bp
177-288°C) in a pressure stove under the
conditions approximating those in a
kitchen. Soot layers deposited on the
porcelain crucible kept under the flame
were collected and used for the inoculation.
Chemical compositions of soot as well as
particle size distribution of dust and soot
have been reported elsewhere (3).
Male albino rats (120-150 g) were
divided into four subgroups. One group
received an intratracheal inoculation of
5 mg ofkerosene soot in 1 ml of corn oil;
the second group received 5 mg of
chrysotile, administered similarly; the third
group received both kerosene soot and
chrysotile. The fourth group, control rats,
received only 1 ml ofcorn oil. Six animals
from each group were sacrificed 1, 4, 8, 16,
30, 90, and 150 days after exposure by
decapitation; their lungs were removed and
homogenized in 0.25 M sucrose. Lung
microsomal and cytosolic fractions were
isolated (6).
Total cytochrome P450 (7),
benzo[a]pyrene (B[a]P) hydroxylase (8),
epoxide hydrase (9), glutathione S-trans-
ferase (GST) (10) and protein (11) were
assayed by standardized methods. The
results were presented as mean ± standard
error (SE) ofsix animals. Statistical signifi-
cance was determined by Student's t-test
(two-tailed) and a value ofp < 0.05 was
considered significant.
Results
Exposure ofkerosene soot resulted in a sig-
nificant induction of microsomal
cytochrome P450 in rat lungs after 1, 4, 8,
16, 30, 90, and 150 days with a maximum
induction (- 570%) at day 1, followed by
a gradual loss in the induction of
cytochrome P450 (Table 1). However,
chrysotile exposure significantly depleted
lung microsomal cytochrome P450 content
on days 1 and 4 only, while after 30, 90,
and 150 days an increase in the hemopro-
tein content was observed. Simultaneous
exposure to chrysotile and soot significantly
depleted cytochrome P450 in rat lungs up
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Table 1. Effect of kerosene soot and Indian chrysotile asbestos on phase and phase 11 drug-metabolizing enzymes in rat lungs.
Posttreatment period, days
Parameters 1 4 8 16 30 90 150
Cytochrome P450, nmole/mg protein
Control 0.23 ± 0.01 0.24± 0.01 0.19 ± 0.01 0.21 ± 0.01 0.19± 0.01 0.25± 0.02 0.28± 0.01
Soot 1.31 ± 0.038 1.04± 0.02a 0.66± 0.028 0.59±0.018 0.38± 0.01a 0.36± 0.03c 0.42± 0.028
Chrysotile 0.17 ± 0.01b 0.20 ± 0.O1C 0.17 ± 0.01(NS) 0.20 ± 0.01 (NS) 0.23 ± 0.01C 0.32 ± 0.01C 0.56 ± 0.021
Chrysotile + soot 0.37 ± 0.01lxx' 0.41 ± 0.02ax 0.29 ± 0.028a.' 0.44 ± 0.018ax 0.45 ± 0.02axxx' 0.69 ± 0.02a.x.' 0.65 + 00la,x,"
Benzo[a]pyrene hydroxylase, fluorescence units/min/mg protein
Control 0.24 ± 0.03 0.23 ± 0.01 0.26 ± 0.03 0.20 ± 0.02 0.28 ± 0.02 0.29 ± 0.02 0.27 ± 0.01
Soot 0.81 ±0.01a 0.75±0.01a 0.51 ± 0.02a 0.41 ± 0.03a 0.64± O.Ola 0.78± 0.02a 0.84± 0.02a
Chrysotile 0.16 ± 0.01 0.18 ± 0.01 0.16 ± 0.03d 0.20 ± 0.01 (NS) 0.40 ± 0.02b 0.77 ± 0.028 1.02 ± 0.058
Chrysotile + soot 0.27 ± 0.01(NS)x' 0.27 ± 0.01cx,' 0.29 ± 0.01 (NS) x" 0.22 ± 0.02 (NS)x8* 0.58 ± 0.01a,' 0.90 ± 0.a1x,' 1.22 ± 0.05a8.8"'
Epoxide hydrase, fluorescence units/hr/mg protein
Control 0.70 ± 0.05 0.60 ± 0.03 0.69± 0.01 0.99 ± 0.06 0.95 ± 0.04 1.06± 0.01 1.13 ± 0.02
Soot 2.64 ± 0.06a 2.06 ± 0.01a 1.85 ± 0.1la 1.54 ± 0.08a 1.82 ± 0.02a 1.87 ± 0.08a 2.28 ± 0.13a
Chrysotile 0.55± 0.01C 0.51 ±0.02d 0.61 ±0.02b 0.92± 0.03 (NS) 1.32± 0.028 1.78± 0.068 2.63± 0.058
Chrysotile + soot 0.97 ± 0.05bx' 0.86 ± 0.04a8' 1.08 ± 0.05a.. 1.24 ± 0.02bxx' 2.31 ± 0.018.8x' 2.41 ± 0.068ax' 3.33 ± 0.27ax
Glutathione S-transferase, nmole 1-chloro-2,4-dinitrobenzene conjugated/min/mg protein
Control 125 ± 0.36 126 ±0.50 129± 1.83 125± 1.62 128 ± 0.27 141 ±2.18 129± 1.62
Soot 146 ± 5.34b 151 ± 0.448 168± 3.918 172± 4.068 141 ± 2.00 129 ± 3.98 120± 1.72b
Chrysotile 113 ± 1.438 113 ± 1.33a 116± 4.97c 120± 4.71 (NS) 112± 3.068 120± 7.73d 103± 6.90b
Chrysotile + soot 140± 2.84a,(NS)Y 142± 3.24a8xxx' 141 ±4.40cx" 151 ± 5.32axx-' 133± 2.29(NS)xxx, 126± 2.98b(NS)(NS) 108± 1.27ax(NS)
Values represent mean ± SE (N= 6). Significance compared to control: ap< 0.001; bp< 0.01; Cp< 0.02; dp< 0.05; NS, not significant. Significance compared to soot: xp< 0.001;
xXp< 0.01; lp< 0.02; l'p< 0.05; NS, not significant. Significance compared to chrysotile: 'p<0.001; "p<0.01; ..p < 0.02;*"".p < 0.05.
to 16 days after exposure. There was a sig-
nificant induction in the hemoprotein con-
tent at longer treatment periods as
compared to soot alone. However, coexpo-
sure to chrysotile and soot increased the
cytochrome P450 content in lung micro-
somes compared to the effect of chrysotile
alone. B[a]P hydroxylase and epoxide
hydrase followed a similar pattern.
In the cytosolic fraction obtained from
experimental animals, there was a small but
statistically significant increase in the activ-
ity ofGST 1, 4, 8, and 30 days after expo-
sure to soot followed by inhibition of that
activity on days 90 and 150. Exposure to
chrysotile alone showed a significant inhi-
bition in the activity of GST at all time
intervals, as did coexposure to chrysotile
and soot compared to soot alone, while the
enzyme activity was significantly higher
after up to 30 days, compared to chrysotile
alone.
Discussion
Pulmonary phase I and phase II drug
metabolizing enzyme systems play an
important role in both the metabolic acti-
vation and deactivation of a variety of
lipophilic chemical carcinogens, rendering
them hydrophilic prior to their rapid clear-
ance from the body (12). In the initial
stages of combined exposure to chrysotile
and soot, the significant decrease in the
activity ofB[a]P hydroxylase and depletion
of cytochrome P450 levels, compared to
the effect ofsoot exposure alone, may slow
down the metabolism of procarcinogenic
substances in soot in the lung, retarding
the clearance of the lipophilic procarcino-
gens (2,3). The accumulated procarcino-
gens may then increase the number of
fibers penetrating the epithelium, increas-
ing their persistence. This has been
observed with cigarette smoke and asbestos
(13). However, in the later stages after
exposure, a reverse pattern with a progres-
sive increase in the cytochrome P450 con-
tents was recorded, although the reason for
the change in response is not clear.
However, depletion in the cytochrome
P450 levels and associated B[a]P hydroxy-
lase activity may be due to the interaction
ofvarious carcinogenic substances with the
microsomal membrane, which may in turn
lead to destabilization of the cytochrome
P450 assembly (2). The induction of
cytochrome P450, as observed during the
late stages of both asbestos exposure alone
and in combination with soot, may be due
to stimulation of transcription regulatory
elements of the cytochrome P450 gene by
asbestos-mediated slow release of heme
during the initial stages of exposure (2).
The heme released may also be involved in
the generation of reactive oxygen species
which catalyzes the oxidation of 6-
hydroxyB[a]P to 6-oxoB[a]P (14), thereby
playing an important role in the promotion
ofthe multistage processes ofchemical car-
cinogenesis (15).
The increase in activity of epoxide
hydrase monitored in the advanced stages
of coexposure to chrysotile and soot may
produce more reactive carcinogenic epox-
ides. Further, due to the inhibition of
GST activity in the late stages, epoxides
may persist for longer and may be able to
react with biological macromolecules, lead-
ing to a potential increase of lung cancer
(2). Additional evidence on disease devel-
opment in asbestos-exposed subjects may
be derived from the fact that the incidence
of bronchogenic carcinoma in smoking
subjects is much higher than in nonsmok-
ers (16).
These studies in rats indicate that
chrysotile, together with kerosene soot,
influences the clearance mechanism of the
lung by altering the activities of drug
metabolizing enzymes. This results in the
retention oftoxic compounds in the system
which may lead to multiple hits with time
causing neoplastic progression.
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